Rare Diseases: Inserm Transfert Novartis Announces Signing A License Agreement With MyPharma Edition
Posted on Tuesday, May 17th, 2022 Inserm Transfert has just announced the signing of a licensing agreement with Novartis for the work, based on research by Professor Guillaume Canaud at the Institut Necker – Enfants Malade (INEM), of which Inserm is a supervisor. The results of this study aim to restore alpelisib in the indications … Read more